Nothing Special   »   [go: up one dir, main page]

EP4208462A4 - Rivaroxaban compositions - Google Patents

Rivaroxaban compositions

Info

Publication number
EP4208462A4
EP4208462A4 EP21863854.2A EP21863854A EP4208462A4 EP 4208462 A4 EP4208462 A4 EP 4208462A4 EP 21863854 A EP21863854 A EP 21863854A EP 4208462 A4 EP4208462 A4 EP 4208462A4
Authority
EP
European Patent Office
Prior art keywords
rivaroxaban
compositions
rivaroxaban compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21863854.2A
Other languages
German (de)
French (fr)
Other versions
EP4208462A1 (en
Inventor
Vaibhavi Shah
Ravindranath Gampa
Asis Maiti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inventia Healthcare Ltd India
Original Assignee
Inventia Healthcare Ltd India
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inventia Healthcare Ltd India filed Critical Inventia Healthcare Ltd India
Publication of EP4208462A1 publication Critical patent/EP4208462A1/en
Publication of EP4208462A4 publication Critical patent/EP4208462A4/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2813Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
EP21863854.2A 2020-09-05 2021-09-04 Rivaroxaban compositions Pending EP4208462A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202021038382 2020-09-05
PCT/IN2021/050855 WO2022049602A1 (en) 2020-09-05 2021-09-04 Rivaroxaban compositions

Publications (2)

Publication Number Publication Date
EP4208462A1 EP4208462A1 (en) 2023-07-12
EP4208462A4 true EP4208462A4 (en) 2024-09-11

Family

ID=80491661

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21863854.2A Pending EP4208462A4 (en) 2020-09-05 2021-09-04 Rivaroxaban compositions

Country Status (2)

Country Link
EP (1) EP4208462A4 (en)
WO (1) WO2022049602A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006072367A1 (en) * 2004-12-24 2006-07-13 Bayer Healthcare Ag Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release
WO2010146179A2 (en) * 2009-06-18 2010-12-23 Krka, Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising rivaroxaban
US20170000799A1 (en) * 2013-12-23 2017-01-05 Laboratorios Del Dr. Esteve, S.A. Oral pharmaceutical composition
US20180214453A1 (en) * 2015-08-05 2018-08-02 Interquim, S.A. Rivaroxaban pharmaceutical compositions
CN109419778A (en) * 2017-08-22 2019-03-05 正大天晴药业集团股份有限公司 A kind of razaxaban tablet and preparation method thereof
EP3505160A1 (en) * 2017-12-31 2019-07-03 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Preparation of a solid pharmaceutical composition comprising rivaroxaban and production thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10355461A1 (en) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
WO2013022924A1 (en) * 2011-08-08 2013-02-14 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations
WO2015124995A1 (en) * 2014-02-19 2015-08-27 Aurobindo Pharma Ltd Solid dosage forms of rivaroxaban

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006072367A1 (en) * 2004-12-24 2006-07-13 Bayer Healthcare Ag Solid, orally applicable pharmaceutical administration forms containing rivaroxaban having modified release
WO2010146179A2 (en) * 2009-06-18 2010-12-23 Krka, Tovarna Zdravil, D.D., Novo Mesto Solid pharmaceutical composition comprising rivaroxaban
US20170000799A1 (en) * 2013-12-23 2017-01-05 Laboratorios Del Dr. Esteve, S.A. Oral pharmaceutical composition
US20180214453A1 (en) * 2015-08-05 2018-08-02 Interquim, S.A. Rivaroxaban pharmaceutical compositions
CN109419778A (en) * 2017-08-22 2019-03-05 正大天晴药业集团股份有限公司 A kind of razaxaban tablet and preparation method thereof
EP3505160A1 (en) * 2017-12-31 2019-07-03 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. Preparation of a solid pharmaceutical composition comprising rivaroxaban and production thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2022049602A1 *

Also Published As

Publication number Publication date
WO2022049602A1 (en) 2022-03-10
EP4208462A1 (en) 2023-07-12

Similar Documents

Publication Publication Date Title
GB202013432D0 (en) Compositions
GB202015836D0 (en) Compositions
GB202100097D0 (en) Novel composition
GB202105461D0 (en) Compositions
GB202102704D0 (en) Compositions
GB202019952D0 (en) Novel compositions
GB202017863D0 (en) Novel compositions
GB202103073D0 (en) Novel composition
GB202102258D0 (en) Novel composition
EP4208462A4 (en) Rivaroxaban compositions
ZA202210764B (en) Compositions
GB202208611D0 (en) Compositions
GB202118081D0 (en) Compositions
GB202117074D0 (en) Compositions
GB202116861D0 (en) Compositions
GB202116386D0 (en) Compositions
GB202116388D0 (en) Compositions
GB202116387D0 (en) Compositions
GB202115617D0 (en) Compositions
GB202114053D0 (en) Compositions
GB202111897D0 (en) Compositions
GB202109944D0 (en) Compositions
GB202109945D0 (en) Compositions
GB202109947D0 (en) Compositions
GB202108656D0 (en) Compositions

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230317

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: INVENTIA HEALTHCARE LIMITED

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240809

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 413/14 20060101ALI20240805BHEP

Ipc: A61K 9/28 20060101ALI20240805BHEP

Ipc: A61P 7/00 20060101ALI20240805BHEP

Ipc: A61P 3/00 20060101ALI20240805BHEP

Ipc: A61K 9/20 20060101ALI20240805BHEP

Ipc: A61K 31/5377 20060101ALI20240805BHEP

Ipc: C07D 413/10 20060101AFI20240805BHEP